KRONOS BIO INC (KRON)
US50107A1043 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to KRON. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.34. This target is 333.5% above the current price.
KRON was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about KRON.
In the previous month the buy percentage consensus was at a similar level.
KRON was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-19 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-18 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-10 | Goldman Sachs | Maintains | Buy |
| 2022-11-09 | Piper Sandler | Maintains | Overweight |
| 2022-09-14 | Berenberg | Initiate | Buy |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-05-23 | Piper Sandler | Maintains | Overweight |
| 2022-02-28 | Piper Sandler | Maintains | Overweight |
| 2021-11-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-24 | HC Wainwright & Co. | Initiate | Buy |